Company Filing History:
Years Active: 1991
Title: Noriyuki Tsunekawa: Innovator in Medical Biotechnology
Introduction
Noriyuki Tsunekawa is a prominent inventor based in Hino, Japan. He has made significant contributions to the field of medical biotechnology, particularly in the development of innovative methods for diagnosing and treating diseases. With a total of 2 patents to his name, Tsunekawa's work has the potential to impact patient care significantly.
Latest Patents
Tsunekawa's latest patents include a method of detecting Kawasaki disease using anti-tumor necrosis antibody. This method involves confirming the diagnosis of Kawasaki disease in a patient by assaying the patient's body fluid for elevated levels of a substance specifically bound by an anti-tumor necrosis factor monoclonal antibody. Another notable patent is for muteins of tumor necrosis factor, which describes a novel physiologically active polypeptide with antitumor activity. This polypeptide is derived from human tumor necrosis factor (TNF) but has been modified to enhance its efficacy and reduce side effects, particularly cytotoxicity.
Career Highlights
Tsunekawa is currently associated with Teijin Limited, a company known for its advancements in various fields, including healthcare and materials. His work at Teijin has allowed him to focus on innovative solutions that address critical medical challenges.
Collaborations
Some of Tsunekawa's notable coworkers include Kenji Yone and Jun Suzuki. Their collaborative efforts have contributed to the development of groundbreaking technologies in the medical field.
Conclusion
Noriyuki Tsunekawa's contributions to medical biotechnology through his patents and work at Teijin Limited highlight his role as an influential inventor. His innovative approaches to diagnosing and treating diseases continue to pave the way for advancements in healthcare.